BIANCO, ROBERTO

BIANCO, ROBERTO  

Dipartimento di Medicina clinica e Chirurgia  

Mostra records
Risultati 1 - 20 di 150 (tempo di esecuzione: 0.028 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
1599P - Effects of Hedgehog signaling inhibition on epithelial-stromal interactions in triple negative breast cancer cells 1.5 Abstract in rivista 2014 Servetto, A.; Raimondo, L.; Formisano, L.; Marciano, R.; Di Mauro, C.; Rosa, R.; D'Amato, V.; Veneziani, BIANCA MARIA; DE PLACIDO, Sabino; Bianco, Roberto
A novel mdm2 antisense oligonucleotide has antitumor activity and potentiates cytotoxic drugs acting by different mechanisms in human colon cancer. 1.1 Articolo in rivista 2000 Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Chen, J; Agrawal, S; Bianco, Ar; Ciardiello, F.
A Novel Toll-Like Receptor 9 Agonist Cooperates with Trastuzumab in Trastuzumab-Resistant Breast Tumors through Multiple Mechanisms of Action 1.1 Articolo in rivista 2009 Damiano, Vincenzo; Bianco, Roberto; Garofalo, Sonia; Rosa, Roberta; R., Caputo; Gelardi, Teresa; G., Merola; Racioppi, Luigi; Garbi, Corrado; Tortora, Giampaolo
A phase II study of beweekly oxaliplatin plus infusional 5fluorouracil and folinic acid (FOLFOX4) as first-line treatment of advenced gastric cancer patients 1.5 Abstract in rivista 2004 F., De Vita; M., Orditura; Matano, Elide; Bianco, Roberto; Carlomagno, Chiara; S., Infusino; Damiano, Vincenzo; E., Simeone; Mr, Diadema; E., Lieto; P., Castellano; S., Pepe; DE PLACIDO, Sabino; G., Galizia; F., Ciardiello; G., Catalano; Ar, Bianco
Addition of erlotinib to fluoropyrimidine-oxaliplatin-basedchemotherapy with or without bevacizumab: Two sequential phase I trials 1.1 Articolo in rivista 2011 Carlomagno, Chiara; Gennaro, Daniele*; Bianco, Roberto; Marciano, Roberta; Damiano, Vincenzo; Elide, Matano; Nappi, Lucia; Stefano, Pepe; DE PLACIDO, Sabino; Giampaolo, Tortora
Adjuvant FOLFOX-4 in patients with radically resected gastric cancer: tolerability, and prognostic factors. 1.1 Articolo in rivista 2010 Carlomagno, Chiara; Elide, Matano; Bianco, Roberto; Carolina, Cimminiello; Antonella, Prudente; Clorindo, Pagliarulo; Anna, Crispo; Lucia, Cannella; DE STEFANO, Alfonso; D'Armiento, FRANCESCO PAOLO; DE PLACIDO, Sabino
Afatinib: An overview of its clinical development in non-small-cell lung cancer and other tumors 1.2 Recensione in rivista 2015 Giordano, Pasqualina; Manzo, Anna; Montanino, Agnese; Costanzo, Raffaele; Sandomenico, Claudia; Piccirillo, Maria Carmela; Daniele, Gennaro; Normanno, Nicola; Carillio, Guido; Rocco, Gaetano; Bianco, Roberto; Perrone, Francesco; Morabito, Alessandro
Angiogenic and signalling proteins correlate with sensitivity to sequential treatment in renal cell cancer 1.1 Articolo in rivista 2013 Rosa, Roberta; Damiano, Vincenzo; Nappi, Lucia; Formisano, Luigi; Massari, F.; Scarpa, A.; Martignoni, G.; Bianco, Roberto; Tortora, G.
Antiangiogenic and antitumor activity of anti-EGFR C225 monoclonal antibody in combination with Vascular Endothelial Growth Factor antisense oligonucleotide in human GEO colon cancer cells. 1.1 Articolo in rivista 2000 Ciardiello, F; Bianco, Roberto; Damiano, Vincenzo; Fontanini, G; Caputo, R; Pomatico, G; DE PLACIDO, Sabino; Bianco, Ar; Mendelsohn, J; Tortora, Giampaolo
Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A. 1.1 Articolo in rivista 1996 Ciardiello, Fortunato; Damiano, Vincenzo; Bianco, Roberto; C., Bianco; G., Fontanini; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; J., Mendelsohn; Bianco, ANGELO RAFFAELE; Tortora, Giampaolo
Antitumor activity of combined treatment of human cancer cells with ionizing radiations and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide. 1.1 Articolo in rivista 2000 Bianco, C; Bianco, Roberto; Tortora, Giampaolo; Damiano, Vincenzo; Guerrieri, P; Montemaggi, P; Mendelsohn, J; DE PLACIDO, Sabino; Bianco, Ar; Ciardiello,
Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225. 1.1 Articolo in rivista 1999 Ciardiello, F; Bianco, Roberto; Damiano, Vincenzo; DE LORENZO, Sonya; Pepe, Stefano; DE PLACIDO, Sabino; Fan, Z; Mendelsohn, J; BIANCO A., R; Tortora, Giampaolo
ANTITUMOR ACTIVITY OF THE COMBINATION OF CETUXIMAB, AN ANTI-EGFR BLOCKING MONOCLONAL ANTIBODY AND ZD6474, AN INHIBITOR OF VEGFR AND EGFR TYROSINE KINASES. 1.1 Articolo in rivista 2006 Morelli, Mp; Cascone, T; Troiani, T; Tuccillo, C; Bianco, Roberto; Normanno, N; Romano, M; Veneziani, BIANCA MARIA; Fontanini, G; Eckhardt, Sg; DE PLACIDO, Sabino; Tortora, Giampaolo; Ciardiello, F.
Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model. 1.1 Articolo in rivista 2004 Raben, D; Bianco, C; Damiano, Vincenzo; Bianco, Roberto; Melisi, Davide; Mignogna, C; D'Armiento, FRANCESCO PAOLO; Cionini, L; Bianco, Ar; Tortora, Giampaolo; Ciardiello, F; Bunn, P.
Antitumor activity of ZD6474, a small molecule VEGF receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to EGF receptor-targeted drugs. 1.5 Abstract in rivista 2003 Ciardiello, F; Bianco, Roberto; Caputo, R; Caputo, R; Damiano, V; Veneziani, BIANCA MARIA; De Vita, F; DE PLACIDO, Sabino; Bianco, Ar; Tortora, G.
Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy. 1.1 Articolo in rivista 2004 Ciardiello, F; Bianco, Roberto; Caputo, R; Caputo, R; Damiano, Vincenzo; Troiani, T; Melisi, D; DE VITA, F; DE PLACIDO, Sabino; Bianco, Ar; Tortora, G.
ANTITUMOR ACTIVITY OF ZD6474, A VEGFR-2 AND EGFR SMALL MOLECULE TYROSINE KINASE INHIBITOR, IN COMBINATION WITH SC-236, A CYCLOOXYGENASE-2 INHIBITOR. 1.1 Articolo in rivista 2005 Tuccillo, C; Romano, M; Troiani, T; Martinelli, E; Morgillo, F; DE VITA, F; Bianco, Roberto; Fontanini, G; Bianco, Ar; Tortora, Giampaolo; AND CIARDIELLO, F.
Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an EGFR-selective tyrosine kinase inhibitor. 1.1 Articolo in rivista 2000 Ciardiello, F; Caputo, R; Bianco, Roberto; Damiano, Vincenzo; Pomatico, G; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo
Approaches for targeting cancer stem cells drug resistance 1.1 Articolo in rivista 2016 Rosa, Roberta; D'Amato, Valentina; DE PLACIDO, Sabino; Bianco, Roberto
Association of FGFR1 with ERαmaintains ligand-independent ER transcription and mediates resistance to estrogen deprivation in ER+ breast cancer 1.1 Articolo in rivista 2017 Formisano, Luigi; Stauffer, Kimberly Mae; Young, Christian D; Bhola, Neil E; Guerrero Zotano, Angel L; Jansen, Valerie M; Estrada, Monica M; Hutchinson, Katherine E; Giltnane, Jennifer M; Schwarz, Luis J; Lu, Yao; Balko, Justin M; Deas, Olivier; Cairo, Stefano; Judde, Jean Gabriel; Mayer, Ingrid A; Sanders, Melinda; Dugger, Teresa C; Bianco, Roberto; Stricker, Thomas; Arteaga, Carlos L.